Greta Ann Herin

Affiliations: 
Eastern Mennonite University, Harrisonburg, VA, United States 
Google:
"Greta Herin"
Mean distance: 14.48 (cluster 11)
 
SNBCP

Parents

Sign in to add mentor
Elias Aizenman grad student 1997-2003 University of Pittsburgh
 (Studies on the role of the N -terminal domain of NR1 in the redox modulation of NR2A-containing NMDA receptors.)
Heinrich Betz post-doc MPI for Brain Research
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhang CS, Bertaso F, Eulenburg V, et al. (2008) Knock-in mice lacking the PDZ-ligand motif of mGluR7a show impaired PKC-dependent autoinhibition of glutamate release, spatial working memory deficits, and increased susceptibility to pentylenetetrazol. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8604-14
Caldwell JH, Herin GA, Nagel G, et al. (2008) Increases in intracellular calcium triggered by channelrhodopsin-2 potentiate the response of metabotropic glutamate receptor mGluR7. The Journal of Biological Chemistry. 283: 24300-7
Herin GA, Aizenman E. (2004) Amino terminal domain regulation of NMDA receptor function. European Journal of Pharmacology. 500: 101-11
Lu Y, Li Y, Herin GA, et al. (2004) Elevation of intracellular cAMP evokes activity-dependent release of adenosine in cultured rat forebrain neurons. The European Journal of Neuroscience. 19: 2669-81
Legos JJ, McLaughlin B, Skaper SD, et al. (2002) The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. European Journal of Pharmacology. 447: 37-42
Herin GA, Du S, Aizenman E. (2001) The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site. Journal of Neurochemistry. 78: 1307-14
Aizenman E, Sinor JD, Brimecombe JC, et al. (2000) Alterations of N-methyl-D-aspartate receptor properties after chemical ischemia. The Journal of Pharmacology and Experimental Therapeutics. 295: 572-7
See more...